Skin disorders, Guidance

Applied filters

Care Setting (1)
- Neonates (1)
Guidance (84)
- Adverse effects (1)
- Cautions and contraindications (1)
- Excipients (1)
- Medication Safety (1)
- Porphyria (1)
- Safety in Breastfeeding (79)
- Temperature management (9)
  - Stability outside the fridge (9)
Medicine (83)
- Aciclovir (1)
- Acitretin (3)
- Adalimumab (2)
- Adapalene (1)
- Alitretinoin (3)
- Aminolevulinic acid hydrochloride (1)
- Amorolfine (2)
- Azathioprine (2)
- Azelaic acid (2)
- Beclometasone (2)
- Benzoyl peroxide (1)
- Benzyl benzoate (1)
- Betamethasone (2)
- Bimekizumab (1)
- Calcipotriol (2)
- Calcitriol (2)
- Cetrimide (2)
- Chlorhexidine (1)
- Ciclosporin (2)
- Clindamycin (3)
- Clotrimazole (2)
- Co-cyprindiol (2)
- Coal tar (3)
- Cyclomethicone + Isopropyl myristate (1)
- Dapsone (1)
- Demeclocycline (1)
- Diclofenac sodium (1)
- Dimethyl fumarate (1)
- Dimeticone (2)
- Doxepin (1)
- Doxycycline (2)
- Econazole (2)
- Erythromycin (3)
- Etanercept (2)
- Fluocinolone acetonide (2)
- Fluorouracil (1)
- Fluticasone (2)
- Fusidic acid (1)
- Glycopyrronium (1)
- Griseofulvin (2)
- Hydrocortisone (2)
- Hydrogen peroxide (1)
- Ichthammol (2)
- Imiquimod (1)
- Industrial methylated spirit (1)
- Infliximab (2)
- Isotretinoin (4)
- Ivermectin (1)
- Ketoconazole (3)
- Levomenthol (1)
- Lymecycline (2)
- Malathion (2)
- Methotrexate (2)
- Methyl aminolevulinate (1)
- Metronidazole (1)
- Miconazole (2)
- Minocycline (1)
- Minoxidil (2)
- Mometasone (2)
- Mupirocin (2)
- Neomycin (2)
- Nicotinamide (2)
- Nystatin (2)
- Oxytetracycline (1)
- Polymyxin B + Bacitracin (2)
- Potassium permanganate (2)
- Povidone (1)
- Propofol (1)
- Rituximab (1)
- Roflumilast (1)
- Salicylic acid (3)
- Selenium (2)
- Silver nitrate (1)
- Sirolimus (1)
- Soya oil (1)
- Tacrolimus (2)
- Tazarotene (2)
- Terbinafine (2)
- Tetracycline (1)
- Titanium dioxide + Titanium peroxide + Titanium salicylate (1)
- Tretinoin (4)
- Triamcinolone acetonide (1)
- Ustekinumab (2)
Medicines planning (26)
- New Medicines (14)
  - CCG commissioned new medicines (11)
  - NHS England commissioned new medicines (5)
  - Pre-registration new medicines (UK/EU) (4)
- Patent expiries (21)
Specialty (84)
- Allergy and immunology (9)
- Anaesthesia and pain (2)
- Cancers (7)
- Cardiovascular system disorders (2)
- Ear, nose and throat disorders (11)
- Endocrine system disorders (2)
- Eyes and vision (9)
- Gastrointestinal disorders (5)
- Haematological disorders (3)
- Infection and infectious diseases (16)
- Mental health and illness (1)
- Musculo-skeletal disorders (9)
- Neurological disorders (2)
- Nutritional and metabolic disorders (2)
- Obstetrics and gynaecology (1)
- Respiratory disorders (6)
- Skin disorders (84)
- Wounds and injuries (1)

Using potassium permanganate for skin conditions or wound care

15 November 2021Potassium permanganate is a chemical product. We review the evidence for using it in wound care and highlight the risk of severe harm associated with wrong use.

Using aqueous cream as a soap substitute for skin washing

11 November 2021Aqueous cream is no longer recommended as an emollient, but may considered as a soap substitute. However, adverse effects are possible with any use.

Safety in Lactation: Acne and rosacea

30 October 2020Topical preparations for acne are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid contact of…

What issues should be considered in patients with peanut allergy requiring a medicine containing soya?

16 October 2020Peanut and soya belong to the same plant family, so there is concern about cross-sensitivity. This Medicines Q&A (updated April 2020) discusses the issues to…

Safety in Lactation: Tetracyclines

25 September 2020If other antibiotics are not appropriate, tetracycline is the preferred drug from this group. Short term use (less than 3 weeks duration) is acceptable for…

Safety in Lactation: Topical preparations for eczema and psoriasis

23 September 2020Topical preparations for eczema and psoriasis are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid…

Safety in Lactation: Topical corticosteroids

23 September 2020Topical corticosteroids are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid direct contact of the…

Safety in Lactation: Antibacterial skin preparations

23 September 2020Topical preparations for bacterial infections are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to avoid contact…

Safety in Lactation: Antifungal skin preparations

21 September 2020Topical preparations for fungal infections are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to minimise contact…

Safety in Lactation: Preparations for scalp and hair conditions

18 September 2020Shampoos, topical eflornithine (for hirsutism) and minoxidil (for alopecia) are considered to pose a negligible risk to a breastfeeding infant. There is no published evidence…

SPS - Specialist Pharmacy Service

NHS